Upgrading Healthcare Rating to Overweight from Neutral

The omnipresent headlines about the deadly coronavirus underlines the importance of good, reliable healthcare in the modern world. For many other fundamental reasons it’s time for investors to take another look at the lagging U.S. healthcare sector. Thanks to a perspective drop in the sector’s equity risk premium (ERP), reduced federal regulatory risk and a potential sentiment reset, I upgrade the sector to an Overweight rating from Neutral (my stance since Dec. 2015). I’ll list 14 sector...

Finish reading this report for free

Enter your email and we'll send the paywall-free report directly to your inbox

Articles Read: 0/2

By continuing, you agree to the Terms of Service and Privacy Policy.

In addition to your unlocked report, you will receive our weekly market newsletter Fundstrat Snapshot, as well as occasional updates and offers from Fundstrat Direct. You can unsubscribe at any time.

Get unlimited access to Tom Lee's Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Events

Trending tickers in our research